Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis - Quiz - MDSpire

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

  • By

  • Derrick Robertson

  • Enrique Alvarez

  • Lawrence Steinman

  • Hans-Peter Hartung

  • Peiqing Qian

  • Krzysztof Selmaj

  • Sibyl Wray

  • Daniel Wynn

  • Edward J. Fox

  • Koby Mok

  • Hari P. Miskin

  • Yihuan Xu

  • Christopher A. Garner

  • Bruce A. C. Cree

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

  • by Derrick Robertson, Enrique Alvarez, Lawrence Steinman, Hans-Peter Hartung, Peiqing Qian, Krzysztof Selmaj, Sibyl Wray, Daniel Wynn, Edward J. Fox, Koby Mok, Hari P. Miskin, Yihuan Xu, Christopher A. Garner, Bruce A. C. Cree

  • May 29, 2026

Related Content

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Non-Linear Measures of Movement Variability in Multiple Sclerosis: A Clinical Narrative Review of Lyapunov Exponent and Entropy Applications in Balance and Gait

Enrichment of Immature CD10low Neutrophils in Individuals Diagnosed with Multiple Sclerosis